Androgenetic Alopecia

Summarized by Plex Health
Last Updated: 02 May 2022
scalp dermatoscopic findings in androgenetic alopecia and their relations with disease severity. "scalp dermatoscopic findings in androgenetic alopecia and their relations with disease severity.", by Kibar M, Aktan S, Bilgin M. F1: (A) Perifollicular pigmentation, brown dots, white dots, miniaturization, and hair diameter diversity in a 65-year-old patient with male androgenetic alopecia Hamilton Norwood stage 5. (B) Miniaturization, hair diameter diversity, white dots, and perifollicular pigmentation...

Androgenetic alopecia is a common type of loss of hair in both women and men. The pattern of hair loss in women varies from men. Androgenetic alopecia in women hardly ever causes overall baldness. In enhancement to male-pattern baldness, androgenetic alopecia in men has been connected with a number of other clinical problems consisting of coronary cardiovascular disease and enlargement of the prostate. Only 2 drugs presently have United States Food and Drug Administration accepted indicators for therapy of androgenetic alopecia: Minoxidil: Appears to lengthen the duration of the anagen phase, and it might increase the blood supply to the follicle. Minoxidil use for numerous months can result in an eye problem understood as central chorioretinopathy, which can return to normal after 1 months of not using the medicine. Finasteride has no recognized side effects in men, according to several research studies, but it can not be used in women who are still attempting to have children because it may create fetal genital malformations. Some drugs that are not accepted by the FDA however might be handy are: Spironalactone: In women with androgenetic alopecia. Some studies have shown that this medicine might be helpful for stimulating hair roots activity and dealing with loss of hair. Surgical treatment of androgenetic alopecia has good cosmetic results. It is necessary for the patients with androgenetic alopecia to be evaluated for treatable reasons for telogen effluvium like anemia or hypothyroidism, particularly in patients that had a rapid progress of their disease or an abrupt begin of the disease.

* Please keep in mind that all text is summarized by machine, we do not bear any responsibility, and you should always check original source before taking any actions

** If you believe that content on the Plex is summarised improperly, please, contact us, and we will get rid of it quickly; please, send an email with a brief explanation.

*** If you want us to remove all links leading to your domain from Plex.page and never use your website as a source of the "Online Knowledge", please contact us using a corporate email and we will remove everything in 10 business days.

logo

Plex Page is a Biology & Health Sciences "Online Knowledge Base," where a machine summarizes all the summaries.